RESEARCH —
THE BEST HOPE AGAINST CANCER.
We are Cancer Research Venture Philanthropists, making early investments in bold ideas in the fight against cancer. Help us fund tomorrow’s cancer game-changers today.
We are Cancer Research Venture Philanthropists, making early investments in bold ideas in the fight against cancer. Help us fund tomorrow’s cancer game-changers today.
Our mission is to fund early-career cancer scientists and new directions in cancer science research with the goal of contributing to “Transformational Events” in the prevention, treatment and cure for cancer.
The CRF YIA was established nearly 30 years ago to address a common problem in the early part of a cancer researcher’s career: to secure funding as a principal investigator, a scientist must present primary data, but to gather that data a scientist must have funding…
Learn MoreThe Fletcher Scholars Award was established in 1988 with a gift from the estate of Eugene and Dorothy S. Fletcher. With this gift, the Cancer Research Foundation established the Fletcher Scholars Award, a $100,000 grant to be given to an individual scientist who is undertaking research in cancer science with particular importance.
Meet the 2020 Fletcher ScholarsThe Young Investigator Award is the Cancer Research Foundation’s preeminent grant making program; these awards represent the CRF’s commitment to funding promising early-career scientists.
Learn MoreThe Cancer Research Foundation is pleased to congratulate our 2014 CRF Young Investigator Dr. Bryan Dickinson, PhD on the development and publication of his CIRTS system. CIRTS, or “CRISPR-Cas Inspired RNA Targeting System,” suggests a way to build on the success of CRISPR-Cas9, the landmark gene editing tool, and a way to address some of the limitations and issues inherent in using CRISPR-Cas.
Learn MoreA podcast from the Cancer Research Foundation. Join us as we interview researchers, innovators, and entrepreneurs who are fighting cancer through their bold ideas in science and technology.
Listen NowOur Young Investigator Award allows the CRF to invest in early-career cancer science in the pursuit of ground-breaking treatments, preventions and a cure for cancer.